Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Metabolically healthy obesity and NAFLD

Obesity is a risk factor for several noncommunicable diseases, but some individuals with obesity remain metabolically healthy throughout life; whether these individuals are at risk of developing NAFLD is uncertain. In a new study, Chang et al. showed a statistically significant, graded relationship between BMI and NAFLD in metabolically healthy individuals.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Chang, Y. et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am. J. Gastroenterol. (2016).

  2. 2

    Bergman, R. N. et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am. J. Med. 120, S3–S8 (2007).

    CAS  Article  PubMed  Google Scholar 

  3. 3

    Kramer, C. K., Zinman, B. & Retnakaran, R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann. Intern. Med. 159, 758–769 (2013).

    Article  PubMed  Google Scholar 

  4. 4

    Roberson, L. L. et al. Beyond BMI: the 'metabolically healthy obese' phenotype and its association with clinical/subclinical cardiovascular disease and all-cause mortality — a systematic review. BMC. Public Health 14, 14 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5

    Ortega, F. B. et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart. J. 34, 389–397 (2013).

    Article  PubMed  Google Scholar 

  6. 6

    Stefan, N. et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609–1616 (2008).

    Article  PubMed  Google Scholar 

  7. 7

    Byrne, C. D. & Targher, G. NAFLD: a multisystem disease. J. Hepatol. 62, S47–S64 (2015).

    Article  PubMed  Google Scholar 

  8. 8

    Sung, K. C., Cha, S. C., Sung, J. W., So, M. S. & Byrne, C. D. Metabolically healthy obese subjects are at risk of fatty liver but not pre-clinical atherosclerosis. Nutr. Metab. Cardiovasc. Dis. 24, 256–262 (2014).

    Article  PubMed  Google Scholar 

  9. 9

    Aune, D. et al. Body mass index and all-cause mortality: a systematic review and nonlinear dose-response meta-analysis of 230 prospective studies with 3.74 million deaths among 30.3 million participants. BMJ 353, i2156 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10

    Afzal, S., Tybjærg-Hansen, A., Jensen, G. B. & Nordestgaard, B. G. Change in body mass index associated with lowest mortality in Denmark, 1976–2013. JAMA 315, 1989–1996 (2016).

    CAS  Article  PubMed  Google Scholar 

Download references


G.T. is supported in part by grants from the University School of Medicine of Verona, Verona, Italy. C.D.B. is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre.

Author information



Corresponding author

Correspondence to Giovanni Targher.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Targher, G., Byrne, C. Metabolically healthy obesity and NAFLD. Nat Rev Gastroenterol Hepatol 13, 442–444 (2016).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing